Research and education at IGP
Welcome to IGP
The department conducts advanced research and education in areas such as clinical immunology, medical genetics and genomics, pathology, oncology, neuro-oncology, vascular biology, molecular tools and medical radiation sciences.
Some of our activities are integrated with clinics at Uppsala University Hospital.
Find examples of research at the department in Our research in images
New research findings from IGP
-
Unmarried and less educated patients receive less extensive therapy
Mantle cell lymphoma is a malignant tumour disease where intensive therapy can prolong survival. A new study from IGP and others shows that people with mantle cell lymphoma who were unmarried and had a lower education level were more seldom treated by stem cell transplantation, which can result in reduced survival. The results have been published in the journal Blood Advances.
-
Beta blockers can repair malformed blood vessels in the brain
Propranolol, a drug that is efficacious against infantile haemangiomas (“strawberry naevi”, resembling birthmarks), can also be used to treat cerebral cavernous malformations, a condition characterised by misshapen blood vessels in the brain and elsewhere. This has been shown by IGP researchers in a new study published in the scientific journal Stroke.
-
Innate immune system aggravates severe COVID-19
In critically ill COVID-19 patients, the innate immune system is strongly activated which can cause thrombosis and reduced oxygenation in the patients. This is shown in a study from IGP, published in the journal Frontiers in Immunology.
News
Newsletter
Twitter IGP
- RT @glimelius: Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower surv…
- Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival | Blood Advances | American Society of Hematology https://t.co/yTMp0cVHQy
- RT @KAWstiftelsen: Läs om uppsalaforskarna som vill hitta nya behandlingar mot obotliga hjärntumörer. De utvecklar en immunterapi med lova…